Physiomics Plc (AIM:PYC)

Market Cap	1.26M
Revenue (ttm)	542.56K
Net Income (ttm)	-634.35K
Shares Out	303.21M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,449,924
Average Volume	3,395,867
Open	0.4320
Previous Close	0.4250
Day's Range	0.4000 - 0.4320
52-Week Range	0.3800 - 1.4000
Beta	0.58
RSI	39.65
Earnings Date	Sep 26, 2025

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 11
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: PYC

Financial Performance

In 2024, Physiomics's revenue was 570,561, a decrease of -5.81% compared to the previous year's 605,734. Losses were -609,352, 27.7% more than in 2023.